MS Care Professionals Need Better Understanding of Medical Marijuana to Address Patient Demand
“Eighty-nine percent of residents and fellows are not prepared to recommend cannabis use to patients, and 33% are not at…
Why NICE Didn’t Approve Roche’s Ocrevus for Multiple Sclerosis
By Sarah Collins Apr 12, 2018 | 9:38 AM Overview On April 5, 2018, Roche’s (RHHBY) MS (multiple sclerosis) drug…
Stuart Schlossman
Evaluation of sexual function in women at two stages of multiple sclerosis
…
Stuart Schlossman
…
Stuart Schlossman
Benefits of Music Therapy for MS
…
Stuart Schlossman
Furor over drug prices puts Patient Advocacy Groups in a Bind
…
Stuart Schlossman
How MS Disability Is Measured
…
Stuart Schlossman
Ari Waisman from the University of Mainz: How the Blood-Brain Barrier Affects Multiple Sclerosis Treatment
…
Stuart Schlossman
Gender Plays Role in Multiple Sclerosis Care and Treatment – Men and Women greatly differ in handling MS
…
Stuart Schlossman
Treating Advanced Disease in Multiple Sclerosis
…
Stuart Schlossman
